In a study involving more than 12,000 individuals with nonalcoholic fatty liver disease (NAFLD), researchers found a significantly increased risk of severe infections requiring hospital admission. NAFLD is considered a manifestation of the metabolic syndrome in the liver and with the global rise in obesity, NAFLD has emerged as the most common chronic liver disease affecting around one quarter of all adults worldwide. It has also become the fastest growing cause of end-stage liver disease, primary liver cancer and liver transplantation. In a study (the ESPRESSO study) involving 12,133 individuals with biopsy-proven NAFLD, and 57,516 matched controls from the general...